Swiss sign next vaccine agreement with AstraZeneca
AstraZeneca is a frontrunner in a Covid-19 vaccine development
Copyright 2020 The Associated Press. All Rights Reserved
Switzerland has signed an agreement with British pharmaceutical company AstraZeneca to pre-order up to 5.3 million doses of a Covid-19 vaccine that is currently under development.
“Given that it is still not clear which vaccines will ultimately prevail, the government is taking a diversified approach,”a statement said on FridayExternal link.
Switzerland has already inked a deal with United States biotech firm Moderna to secure early access to 4.5 million doses of its Covid-19 vaccine.
It has also confirmed its participation in the World Health Organization’s COVAX initiative aimed at ensuring equitable access to Covid-19 vaccines when they are approved.
“The Swiss public will therefore gain access to a further Covid-19 vaccine – provided it successfully passes the clinical trial phase and is approved by Swissmedic,” the statement said.
Europe involvement
The contract with AstraZeneca – and the Swedish government – is based on an agreement between the European Commission and AstraZeneca for the delivery of up to 400 million doses for Europe.
These doses can be ordered by individual states according to their population numbers and procured once the vaccine has been approved. Sweden will order doses for countries like Switzerland which is not a member of the EU but is a member of EFTA (European Free Trade Association) and resell them at no profit.
If approved, the vaccine will be delivered directly to Switzerland by AstraZeneca, which submitted an application for approval of its medicine to Swiss drug authority Swissmedic at the start of October. This was the first time that a drugmaker had presented a coronavirus vaccine for approval in Switzerland.
This content was published on
Swiss drug authority Swissmedic has begun evaluating the so-called “Covid-19 Vaccine AstraZeneca”. It is the first time that a drugmaker has presented a coronavirus vaccine for approval in Switzerland.
Swiss committee wants to end government resignations during legislative term
This content was published on
Members of the Federal Council should no longer be able to leave office before the end of their term, according to a House of Representatives committee.
Swiss government seat: Ritter and Pfister nominated to succeed Amherd
This content was published on
Markus Ritter from St Gallen and Martin Pfister from Zug were officially nominated by the Centre Party on Friday to succeed Defence Minister Viola Amherd.
Top Swiss court rejects Russian request for administrative tax assistance
This content was published on
There is currently no reason to transmit banking information to the Russian Federation, the Swiss Federal Court has ruled.
After strike by radiologists, doctors demonstrate in Bern
This content was published on
Following a strike by radiology technicians in Fribourg, doctors, vets, dentists and chiropractors expressed their frustration on Friday outside parliament in the Swiss capital.
Eurovision and bleak world situation are top themes at Basel carnival
This content was published on
The Eurovision Song Contest and the gloomy global situation are among the main themes of Basel Fasnacht (carnival) this year.
Prices of Swiss investment properties continue to rise despite stagnating rents
This content was published on
Although rents in Switzerland stagnated or fell in the final quarter of last year, prices for investment properties continued to rise. Both apartment buildings and office properties have become more expensive.
Probe into wrong Swiss pension figures clears federal office
This content was published on
Employees of the Swiss Federal Social Insurance Office (FSIO) did not breach their duty of care when calculating pension prospects, an investigation has concluded.
This content was published on
Hotels in the southern Swiss canton of Ticino welcomed significantly more guests last December than in the same month of the previous year.
This content was published on
Switzerland confirms participation in WHO COVAX initiative aimed at ensuring equitable access to Covid-19 vaccines when they are approved.
Switzerland pre-orders 4.5 million doses of Covid-19 vaccine
This content was published on
The Swiss government has signed a deal with US biotech firm Moderna to secure early access to 4.5 million doses of a Covid-19 vaccine currently in development.
This content was published on
It’s the question we all want an answer to: when will there be a vaccine against Covid-19? And how is fair access being negotiated?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.